EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in the use of liquid biopsy to fight central nervous system tumors

Carlos Pilotto Heming, Paulo Niemeyer Filho, Vivaldo Moura-Neto, Veronica Aran

Cancer Treatment and Research Communications · 2023

DOI: 10.1016/j.ctarc.2023.100709 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2023. Verfasst von Carlos Pilotto Heming und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Estadual do Cérebro Paulo Niemeyer (IECPN), R. do Rezende, 156 - Centro, Rio de Janeiro, 20231-092, Brazil. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Central Nervous System Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain tumors are considered one of the deadliest types of cancer, being challenging to treat, especially due to the blood-brain barrier, which has been linked to treatment resistance. The genomic classification of brain tumors has been helping in the diagnostic precision, however tumor heterogeneity in addition to the difficulties to obtain tissue biopsies, represent a challenge. The biopsies are usually obtained either via neurosurgical removal or stereotactic tissue biopsy, which can be risky procedures for the patient. To overcome these challenges, liquid biopsy has become an interesting option by constituting a safer procedure than conventional biopsy, which may offer valuable cellular and molecular information representative of the whole organism. Besides, it is relatively easy to obtain such as in the case of blood (venipuncture) and urine sample collection. In the present comprehensive review, we discuss the newest information regarding liquid biopsy in the brain tumors' field, methods employed, the different sources of bio-fluids and their potential circulating targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingCentral Nervous System NeoplasmsBrain NeoplasmsHumansBiomarkers, TumorLiquid Biopsy

Stichwörter der Autor:innen

Brain tumorsCancer biomarkersCirculating tumor nucleic acidsLiquid biopsyLiquid biopsy target

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Instituto Estadual do Cérebro Paulo Niemeyer (IECPN), R. do Rezende, 156 - Centro, Rio de Janeiro, 20231-092, Brazil.
  • Instituto Estadual do Cérebro Paulo Niemeyer (IECPN), R. do Rezende, 156 - Centro, Rio de Janeiro, 20231-092, Brazil. Electronic address: varanponte@gmail.com.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Ministry of Education

Zitieren

APA

Pilotto Heming, C., Niemeyer Filho, P., Moura-Neto, V., & Aran, V. (2023). Recent advances in the use of liquid biopsy to fight central nervous system tumors. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2023.100709

Vancouver

Pilotto Heming C, Niemeyer Filho P, Moura-Neto V, Aran V. Recent advances in the use of liquid biopsy to fight central nervous system tumors. Cancer Treatment and Research Communications. 2023. doi:10.1016/j.ctarc.2023.100709

BibTeX
@article{PilottoHeming2023,
  author = {Pilotto Heming, Carlos and Niemeyer Filho, Paulo and Moura-Neto, Vivaldo and Aran, Veronica},
  title = {Recent advances in the use of liquid biopsy to fight central nervous system tumors},
  journal = {Cancer Treatment and Research Communications},
  year = {2023},
  doi = {10.1016/j.ctarc.2023.100709}
}
Kostenlos starten →